BME:GRFBiotechs
Is Grifols (BME:GRF) A Bargain On Mixed Half Year Earnings?
Grifols (BME:GRF) has been in focus after its half year 2026 report showed sales of €3,574 million compared to €3,677 million a year earlier, while net income reached €227 million against €177 million.
See our latest analysis for Grifols.
The recent half year 2026 report appears to have been the key driver behind Grifols’ 13.11% 1 month share price return and 12.41% 3 month share price return, although the total shareholder return over 1 and 5 years remains sharply lower. This suggests...